Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Epidermal growth factor reduces hair growth, but cortisol does not.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

EGFR inhibitors can cause yellowish skin eruptions.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

TRPV4 slows hair growth by affecting hair follicle cells.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A new compound shows promise as a topical treatment for hair loss.

HDAC inhibitors help brain cells grow and improve brain function.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Epimedium extract helps increase skin pigmentation and could be a new treatment for conditions with reduced pigmentation.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Tofacitinib may help treat hair loss in children with alopecia areata.